Mahdi Hasani joins Cornell after a successful career at UCLA, where he worked as a project scientist and Faculty Innovation Fellow. Hasani’s expertise lies in biologically inspired biomaterials and drug delivery systems for cancer therapy, tissue regeneration and infectious diseases. His pioneering work on immunomodulatory biomaterials has resulted in over a dozen U.S. patents and several successful biotech ventures.
Hasani’s research focuses on engineering novel drug delivery systems that can rejuvenate the immune system and improve cancer therapies. His work spans areas from polymer electrolyte fuel cells to next-generation cancer vaccines and regenerative tissue engineering.
“I’m thrilled to bring my research in immunoengineering to Cornell, where I’ll have the opportunity to collaborate with experts in a wide range of fields,” Hasani says. “My goal is to develop bio-inspired materials and platforms that can change the way we approach treatment for cancer and autoimmune diseases.”